Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is a critical problem with an impact on both oncological and cardiovascular prognosis, especially when it prevents patients from receiving cancer treatment. Standard therapy for heart failure (HF) is recommended for CTRCD, but th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vanesa Gregorietti, Teresa Lopez Fernandez, Diego Costa, Elías Ortega Chahla, Andrés J. Daniele
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2020-11-01
Colecção:Cardio-Oncology
Assuntos:
Heart failure
Cancer
Cardiotoxicity
Sacubitril/valsartan
Acesso em linha:http://link.springer.com/article/10.1186/s40959-020-00078-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados